Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
901.2500 2.40 (0.27%)
NSE Dec 30, 2025 15:40 PM
Volume: 43,940
 

logo
Alivus Life Sciences Ltd.
27 Jan 2023
901.25
0.27%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Alivus Life Sciences Ltd. is trading above its 30 day SMA of 898.2
More from Alivus Life Sciences Ltd.
Recommended
Market trades flat, Cupid to set up manufacturing facility in Saudi Arabia
Trendlyne Marketwatch | 30 Dec 2025, 03:35PM
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021